Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 By Investing.com

Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 By Investing.com  Investing.com Canada

Summary aggregated from Investing.com Canada's public RSS feed. The full reporting belongs to Investing.com Canada — please read it on their site.